Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
636
datasets available to search
ShareScore release 0.9.0
Dataset results
636 results for “Chimerism”
Chimeric Antigen Receptor Modified T Cells Targeting BCMA for the Treatment of Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06581640. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT06364423. IPD Sharing: YES. Countries: 1. Publications: 0.
Multi-modular Chimeric Antigen Receptor Targeting GD2 in Neuroblastoma
ClinicalTrials.gov study NCT05990751. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chidamide in Combination With Decitabine in Non-Hodgkin's Lymphoma Relapsed After Chimeric Antigen Receptor
ClinicalTrials.gov study NCT04337606. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of TmPSMA-02 Chimeric Antigen Receptor (CAR) T-cells in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
ClinicalTrials.gov study NCT05489991. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Low-dose Decitabine for the Treatment of Decreased Donor Chimerism After Allogeneic Stem Cell Transplantation
ClinicalTrials.gov study NCT03663751. IPD Sharing: NO. Countries: 1. Publications: 0.
NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers
ClinicalTrials.gov study NCT05020678. IPD Sharing: NO. Countries: 2. Publications: 0.
A Phase I Trial of Memory T Cells Expressing an NKG2D Chimeric Antigen Receptor in Children, Adolescents and Young Adults With Advanced Sarcoma
ClinicalTrials.gov study NCT06087341. IPD Sharing: NO. Countries: 1. Publications: 0.
OriCAR-017 Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of R/RMM
ClinicalTrials.gov study NCT06182696. IPD Sharing: NO. Countries: 1. Publications: 0.
Tolerance Through Mixed Chimerism (Sip-Tego)
ClinicalTrials.gov study NCT06972069. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Autoimmune Diseases
ClinicalTrials.gov study NCT06688799. IPD Sharing: NO. Countries: 1. Publications: 0.
Digital Health Intervention for Self-Management and Telemonitoring in Chimeric Antigen Receptor (CAR-T) Therapy
ClinicalTrials.gov study NCT07186192. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Monitoring of Chimerism After Transplantation in Patients With β Thalassemia Major and the Treatment Strategies for the Reduction of Chimerism
ClinicalTrials.gov study NCT03101423. IPD Sharing: Not stated. Countries: 1. Publications: 0.
GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours
ClinicalTrials.gov study NCT07297667. IPD Sharing: YES. Countries: 0. Publications: 0.
A Study to Assess the Pharmacokinetics and Safety of Recombinant Human Murine Chimeric Anti CD20 Monoclonal Antibody Injection (IBI301) Compared to Rituximab Injection in CD20 Positive B Cell Lymphoma
ClinicalTrials.gov study NCT02945215. IPD Sharing: NO. Countries: 1. Publications: 0.
Research Development（RD）13-02 Chimeric Antigen Receptor(CAR) -T Cell Injection for Patients With r/r Cluster Of Differentiation 7（CD7）+ T-Acute Lymphoblastic Leukemia(ALL)/T-Lymphoblastic Lymphoma(LBL
ClinicalTrials.gov study NCT05907603. IPD Sharing: NO. Countries: 1. Publications: 0.
Duvelisib Following Chimeric Antigen Receptor T-Cell Therapy
ClinicalTrials.gov study NCT05044039. IPD Sharing: NO. Countries: 1. Publications: 0.
Serum Neurofilament Light (NfL) as a Marker for Brain Injury in Individuals Undergoing Chimeric Antigen Receptor-modified T Therapy
ClinicalTrials.gov study NCT04614987. IPD Sharing: YES. Countries: 1. Publications: 0.
Intrathecal Cytarabine, Methotrexate, and Hydrocortisone for the Prevention of High-Grade Chimeric Antigen Receptor T-Cell-Associated Neurotoxicity Syndrome
ClinicalTrials.gov study NCT06895473. IPD Sharing: Not stated. Countries: 1. Publications: 0.
FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory Rhabdomyosarcoma
ClinicalTrials.gov study NCT06865664. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.